X-13319002-G-T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001135995.2(ATXN3L):​c.933C>A​(p.His311Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000289 in 1,209,980 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., 3 hem., cov: 23)
Exomes 𝑓: 0.000015 ( 0 hom. 4 hem. )

Consequence

ATXN3L
NM_001135995.2 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.187
Variant links:
Genes affected
ATXN3L (HGNC:24173): (ataxin 3 like) This intronless gene may be a pseudogene (PMID:11450850). This gene is similar to the multi-exon gene which encodes ataxin 3 and contains a coding region which could encode a protein similar to ataxin 3. Mutations in the gene encoding ataxin 3 are associated with Machado-Joseph disease. [provided by RefSeq, Sep 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.045263022).
BS2
High Hemizygotes in GnomAd4 at 3 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ATXN3LNM_001135995.2 linkuse as main transcriptc.933C>A p.His311Gln missense_variant 1/1 ENST00000380622.5 NP_001129467.1 Q9H3M9B4DYC7
ATXN3LNM_001387036.1 linkuse as main transcriptc.669C>A p.His223Gln missense_variant 2/2 NP_001373965.1
GS1-600G8.3NR_046087.1 linkuse as main transcriptn.1449-6G>T splice_region_variant, intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ATXN3LENST00000380622.5 linkuse as main transcriptc.933C>A p.His311Gln missense_variant 1/16 NM_001135995.2 ENSP00000369996.2 Q9H3M9
GS1-600G8.3ENST00000431486.1 linkuse as main transcriptn.1449-6G>T splice_region_variant, intron_variant 1

Frequencies

GnomAD3 genomes
AF:
0.000161
AC:
18
AN:
112028
Hom.:
0
Cov.:
23
AF XY:
0.0000877
AC XY:
3
AN XY:
34212
show subpopulations
Gnomad AFR
AF:
0.000519
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000947
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000110
AC:
2
AN:
181031
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
67461
show subpopulations
Gnomad AFR exome
AF:
0.000162
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000155
AC:
17
AN:
1097952
Hom.:
0
Cov.:
32
AF XY:
0.0000110
AC XY:
4
AN XY:
363384
show subpopulations
Gnomad4 AFR exome
AF:
0.000606
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000217
GnomAD4 genome
AF:
0.000161
AC:
18
AN:
112028
Hom.:
0
Cov.:
23
AF XY:
0.0000877
AC XY:
3
AN XY:
34212
show subpopulations
Gnomad4 AFR
AF:
0.000519
Gnomad4 AMR
AF:
0.0000947
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000188
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000132
ESP6500AA
AF:
0.000381
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00000829
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 14, 2024The c.933C>A (p.H311Q) alteration is located in exon 1 (coding exon 1) of the ATXN3L gene. This alteration results from a C to A substitution at nucleotide position 933, causing the histidine (H) at amino acid position 311 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.74
T
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.36
DANN
Benign
0.38
DEOGEN2
Benign
0.0088
T
FATHMM_MKL
Benign
0.0032
N
LIST_S2
Uncertain
0.89
D
M_CAP
Benign
0.0080
T
MetaRNN
Benign
0.045
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.97
L
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.35
N
REVEL
Benign
0.033
Sift
Benign
0.53
T
Sift4G
Benign
0.58
T
Polyphen
0.015
B
Vest4
0.085
MutPred
0.062
Gain of relative solvent accessibility (P = 0.1066);
MVP
0.38
MPC
0.076
ClinPred
0.0050
T
GERP RS
-0.78
Varity_R
0.078
gMVP
0.018

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs373799323; hg19: chrX-13337121; API